Novel thieno[2,3-d][1,3]oxazin-4-ones as inhibitors of human leukocyte elastase

J Med Chem. 1998 May 7;41(10):1729-40. doi: 10.1021/jm9708341.

Abstract

A series of thieno[2,3-d][1,3]oxazin-4-ones was synthesized and evaluated in vitro for inhibitory activity toward human leukocyte elastase. New synthetic routes to 2-alkoxy-, 2-alkylthio-, and 2-sec-amino-substituted derivatives are reported. This study demonstrates the versatility of 2-aminothiophenes prepared by Gewald reaction as a synthetic entry to serine protease-inhibiting, fused 1,3-oxazin-4-ones. Introduction of ethoxy, n-propoxy, and ethylthio groups at C-2 delivered the most potent inhibitors of this series with Ki values lower than 11 nM. Kinetic studies and product analyses revealed the formation of acyl-enzymes as a result of the attack of the active site serine at the carbon C-4 and subsequent deacylation. This mode of action is similar to the inhibition of serine proteases by 4H-3,1-benzoxazin-4-ones. Replacement of the benzene ring in benzoxazinones by a (substituted) thiophene led to improved hydrolytic stability and retained inhibitory potency.

Publication types

  • Comparative Study

MeSH terms

  • Enzyme Inhibitors* / chemical synthesis
  • Enzyme Inhibitors* / chemistry
  • Enzyme Inhibitors* / pharmacology
  • Humans
  • Hydrolysis
  • Kinetics
  • Leukocyte Elastase / antagonists & inhibitors*
  • Oxazines* / chemical synthesis
  • Oxazines* / chemistry
  • Oxazines* / pharmacology
  • Structure-Activity Relationship
  • Thiophenes* / chemical synthesis
  • Thiophenes* / chemistry
  • Thiophenes* / pharmacology

Substances

  • Enzyme Inhibitors
  • Oxazines
  • Thiophenes
  • Leukocyte Elastase